BB&T Securities’s ResMed RMD Stock Holding History

BB&T Securities’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$6.04M	Buy	44,586 +3,483	+8%	+$456K	0.06%	356
2019 Q2	$5.01M	Buy	41,103 +1,521	+4%	+$168K	0.05%	389
2019 Q1	$4.12M	Buy	39,582 +11,687	+42%	+$1.21M	0.04%	413
2018 Q4	$3.17M	Buy	27,895 +11,069	+66%	+$1.19M	0.04%	443
2018 Q3	$1.94M	Sell	16,826 -2,944	-15%	-$322K	0.02%	622
2018 Q2	$2.05M	Sell	19,770 -446	-2%	-$45.1K	0.02%	594
2018 Q1	$1.99M	Buy	20,216 +7,063	+54%	+$667K	0.02%	573
2017 Q4	$1.11M	Sell	13,153 -174	-1%	-$14.4K	0.01%	716
2017 Q3	$1.02M	Sell	13,327 -1,520	-10%	-$116K	0.01%	736
2017 Q2	$1.16M	Buy	14,847 +7,384	+99%	+$528K	0.02%	683
2017 Q1	$537K	Buy	7,463 +2,433	+48%	+$168K	0.01%	862
2016 Q4	$325K	Hold	5,030	–	–	﹤0.01%	984
2016 Q3	$325K	Buy	5,030 +1,322	+36%	+$88K	﹤0.01%	985
2016 Q2	$234K	Sell	3,708 -942	-20%	-$55.5K	﹤0.01%	1088
2016 Q1	$268K	Buy	+4,650	New	+$263K	﹤0.01%	986

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BB&T Securities's RMD Position: Q3 2019 in Review

BB&T Securities increased its ResMed (RMD) stake by 8.5% in Q3 2019, buying an estimated $456K and bringing the position to 44,586 shares worth $6.04M. The position accounts for 0.06% of the portfolio, ranked #356.

BB&T Securities first reported a position in RMD in Q1 2016 and has held it in 15 quarters since. 528 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

BB&T Securities held 44,586 shares of ResMed worth $6.04M as of Q3 2019.
BB&T Securities bought 3,483 ResMed shares in Q3 2019, an estimated $456K.
ResMed made up 0.06% of BB&T Securities's portfolio in Q3 2019, its #356 holding.
BB&T Securities first reported a position in ResMed in Q1 2016 and has held it in 15 quarters since.
528 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.